These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 38041949

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Metabolomics Analysis Reveals Deranged Energy Metabolism and Amino Acid Metabolic Reprogramming in Dogs With Myxomatous Mitral Valve Disease.
    Li Q, Larouche-Lebel É, Loughran KA, Huh TP, Suchodolski JS, Oyama MA.
    J Am Heart Assoc; 2021 May 04; 10(9):e018923. PubMed ID: 33890477
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Clinical relevance of serum ionized magnesium concentration in dogs with myxomatous mitral valve disease.
    Kim OK, Kim K, Park S, Yang H, Kim H, Ro WB, Lee CM.
    J Vet Intern Med; 2024 May 04; 38(1):41-50. PubMed ID: 38064361
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Serial measurements of cardiac troponin I in heart failure secondary to canine mitral valve disease.
    Chan IP, Wu SY, Chang CC, Chen WY.
    Vet Rec; 2019 Sep 21; 185(11):343. PubMed ID: 31439824
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Temporal changes in clinical and radiographic variables in dogs with preclinical myxomatous mitral valve disease: The EPIC study.
    Boswood A, Gordon SG, Häggström J, Vanselow M, Wess G, Stepien RL, Oyama MA, Keene BW, Bonagura J, MacDonald KA, Patteson M, Smith S, Fox PR, Sanderson K, Woolley R, Szatmári V, Menaut P, Church WM, O'Sullivan ML, Jaudon JP, Kresken JG, Rush J, Barrett KA, Rosenthal SL, Saunders AB, Ljungvall I, Deinert M, Bomassi E, Estrada AH, Fernandez Del Palacio MJ, Moise NS, Abbott JA, Fujii Y, Spier A, Luethy MW, Santilli RA, Uechi M, Tidholm A, Schummer C, Watson P.
    J Vet Intern Med; 2020 May 21; 34(3):1108-1118. PubMed ID: 32200574
    [Abstract] [Full Text] [Related]

  • 9. Echocardiographic parameters for the assessment of congestive heart failure in dogs with myxomatous mitral valve disease and moderate to severe mitral regurgitation.
    Morgan KRS, Monteith G, Raheb S, Colpitts M, Fonfara S.
    Vet J; 2020 Sep 21; 263():105518. PubMed ID: 32928487
    [Abstract] [Full Text] [Related]

  • 10. Heart rate, heart rate variability, and arrhythmias in dogs with myxomatous mitral valve disease.
    Rasmussen CE, Falk T, Zois NE, Moesgaard SG, Häggström J, Pedersen HD, Ablad B, Nilsen HY, Olsen LH.
    J Vet Intern Med; 2012 Sep 21; 26(1):76-84. PubMed ID: 22151356
    [Abstract] [Full Text] [Related]

  • 11. Plasma and serum serotonin concentrations and surface-bound platelet serotonin expression in Cavalier King Charles Spaniels with myxomatous mitral valve disease.
    Cremer SE, Kristensen AT, Reimann MJ, Eriksen NB, Petersen SF, Marschner CB, Tarnow I, Oyama MA, Olsen LH.
    Am J Vet Res; 2015 Jun 21; 76(6):520-31. PubMed ID: 26000599
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Change of Vertebral Left Atrial Size in Dogs With Preclinical Myxomatous Mitral Valve Disease Prior to the Onset of Congestive Heart Failure.
    Lee D, Yun T, Koo Y, Chae Y, Ku D, Chang D, Kang BT, Yang MP, Kim H.
    J Vet Cardiol; 2022 Aug 21; 42():23-33. PubMed ID: 35675727
    [Abstract] [Full Text] [Related]

  • 15. Peripheral blood lymphocyte subtypes in dogs with different stages of myxomatous mitral valve disease.
    Druzhaeva N, Nemec Svete A, Ihan A, Pohar K, Domanjko Petrič A.
    J Vet Intern Med; 2021 Sep 21; 35(5):2112-2122. PubMed ID: 34236111
    [Abstract] [Full Text] [Related]

  • 16. Retrospective evaluation of the utility of shock index to determine the presence of congestive heart failure in dogs with myxomatous mitral valve disease (2019-2021): 98 cases.
    Matson H, Llewellyn EA.
    J Vet Emerg Crit Care (San Antonio); 2024 Sep 21; 34(3):231-237. PubMed ID: 38809224
    [Abstract] [Full Text] [Related]

  • 17. Mitral valve transcriptome analysis in thirty-four age-matched Cavalier King Charles Spaniels with or without congestive heart failure caused by myxomatous mitral valve disease.
    Reimann MJ, Cremer S, Christiansen L, Ibragimov E, Gao F, Cirera S, Fredholm M, Olsen LH, Karlskov-Mortensen P.
    Mamm Genome; 2024 Mar 21; 35(1):77-89. PubMed ID: 37938355
    [Abstract] [Full Text] [Related]

  • 18. Short-term hemodynamic and neuroendocrine effects of pimobendan and benazapril in dogs with myxomatous mitral valve disease and congestive heart failure.
    Häggström J, Lord PF, Höglund K, Ljungvall I, Jöns O, Kvart C, Hansson K.
    J Vet Intern Med; 2013 Mar 21; 27(6):1452-62. PubMed ID: 24128373
    [Abstract] [Full Text] [Related]

  • 19. Severity of myxomatous mitral valve disease in dogs may be predicted using neutrophil-to-lymphocyte and monocyte-to-lymphocyte ratio.
    Ku D, Chae Y, Kim C, Koo Y, Lee D, Yun T, Chang D, Kang BT, Yang MP, Kim H.
    Am J Vet Res; 2023 Jun 01; 84(6):. PubMed ID: 37024099
    [Abstract] [Full Text] [Related]

  • 20. Expression Profiling of Circulating MicroRNAs in Canine Myxomatous Mitral Valve Disease.
    Li Q, Freeman LM, Rush JE, Laflamme DP.
    Int J Mol Sci; 2015 Jun 19; 16(6):14098-108. PubMed ID: 26101868
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.